COST-EFFECTIVENESS (CE) ANALYSES FOR FIRST-LINE (1L) TREATMENT OF ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)

被引：0
|
作者：
Braun, N. [1 ]
Auti, P. [2 ]
Arca, E. [3 ]
Teitsson, S. [4 ]
Broughton, E. [5 ]
May, J. R. [4 ]
Kurt, M. [5 ]
Alleman, C. [3 ]
机构：
[1] OPEN Hlth Evidence & Access, Berlin, Germany
[2] OPEN Hlth Evidence & Access, Thana, MH, India
[3] OPEN Hlth Evidence & Access, Rotterdam, ZH, Netherlands
[4] Bristol Myers Squibb, Uxbridge, Middx, England
[5] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSA58
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC)
    Naqvi, Syed Arsalan Ahmed
    Faisal, Kunwer Sufyan
    Raina, Ammad
    Khakwani, Kaneez Zahra Rubab
    Bin Riaz, Zaryab
    Shah, Vishal S.
    Cobran, Ewan Kemar
    Singh, Parminder
    Hussain, Syed A.
    Bryce, Alan Haruo
    Bin Riaz, Irbaz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COST STUDIES IN PATIENTS RECEIVING FIRST-LINE (1L) THERAPY FOR ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Auti, P.
    Braun, N.
    Arca, E.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S70 - S70
  • [3] Systematic literature review (SLR) and network meta-analysis (NMA) of first-line therapies (1L) for locally advanced/metastatic urothelial carcinoma (la/mUC).
    Bloudek, Lisa
    Hepp, Zsolt
    Mckay, Caroline
    Derleth, Christina Louise
    Lill, Jennifer Susan
    Lenero, Enrique
    Wright, Phoebe
    Ramsey, Scott David
    Sullivan, Sean D.
    Devine, Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)
    Bloudek, Lisa
    Wright, Phoebe
    McKay, Caroline
    Derleth, Christina Louise
    Lill, Jennifer Susan
    Lenero, Enrique
    Hepp, Zsolt
    Ramsey, Scott David
    Sullivan, Sean D.
    Devine, Beth
    CURRENT ONCOLOGY, 2023, 30 (04) : 3637 - 3647
  • [5] Systematic literature review (SLR) and network meta-analysis (NMA) of first-line (1L) therapies for locally advanced/metastatic urothelial carcinoma (la/mUC)
    Bloudek, L.
    Hepp, Z.
    Mckay, C.
    Devine, B.
    Derleth, C.
    Lill, J.
    Lenero, E.
    Wright, P.
    Ramsey, S. D.
    Sullivan, S. D.
    ANNALS OF ONCOLOGY, 2021, 32 : S715 - S715
  • [6] SURVIVAL ANALYSES AND INDIRECT TREATMENT COMPARISONS (ITCS) IN FIRST-LINE METASTATIC UROTHELIAL CARCINOMA (1L MUC)
    Jevdjevic, M.
    Nickel, K.
    Teitsson, S.
    Kurt, M.
    Broughton, E.
    Jain, R.
    Kroep, S.
    VALUE IN HEALTH, 2022, 25 (07) : S333 - S333
  • [7] AVAILABILITY OF PUBLISHED HEALTH-RELATED QUALITY OF LIFE (HRQOL) DATA FOR PATIENTS RECEIVING FIRST-LINE (1L) TREATMENT FOR ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Auti, P.
    Arca, E.
    Braun, N.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S226 - S226
  • [8] CLINICAL AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES FROM INTERVENTIONAL STUDIES IN FIRST-LINE (1L) ADVANCED OR METASTATIC UROTHELIAL CANCER (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Braun, N.
    Auti, P.
    Arca, E.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S19 - S19
  • [9] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
    Karttunen, E.
    Jaaskelainen, S.
    Hervonen, P.
    Chang, J.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
  • [10] Patient-reported outcome (PRO) assessment and reporting in first-line (1L) locally advanced or metastatic urothelial cancer (la/mUC) clinical trials: Results of a systematic literature review (SLR).
    Kearney, Mairead
    Macmillan, Tom
    Poritz, Julia
    Schreiber-Gosche, Sherrie
    Musat, Mihaela Georgiana
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345